Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

NCT06786780 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer Treated with Pelvic Radiotherapy
Cervical Cancers

Interventions

COMBINATION_PRODUCT: Drug: Cisplatin

Sponsor

Chongqing University Cancer Hospital